Netherlands: medicines with the highest expenditure 2023

Leading medicines with the highest expenditure in the Netherlands in 2023 (in million euros)

Medicines with the highest expenditure in the Netherlands 2023

Last update:

Sep 12, 2024

Author:

��ƽ�� Research Department

Region:

Netherlands

Survey time period:

From 01/01/2023 to 31/12/2023

In 2023, rivaroxaban, also sold under the brand name Xarelto and used to treat deep vein thrombosis and pulmonary embolism, was the medicine with the second highest expenditure in the Netherlands. The expenditure for this drug amounted to 129 million euros.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Leading medicines with the highest expenditure in the Netherlands in 2023 (in million euros)

Get in touch with us for additional information

��ƽ��